Pierre Maechler, Universit de Genve) and all clonally-derived cell lines were cultured as described previously 7,10,42
In vivo, tumor-bearing mice were injected intratumorally with LPS in combination with fasting
[1], [2], [3], [4] A 2021 retrospective study conducted at the Institute for Hormonal Balance in Orlando, Florida, that evaluated the use of BPC 157, alone or in combination with thymosin-beta-4 (TB4), indicates in its methodology that no human clinical trials evaluating the use of BPC 157 to help with knee pain have been published (see Table 1)
doi:10.18097/PBMC20166204431
BPC-157 is not FDA-approved for human therapeutic use
This product is strictly intended for in vitro research by qualified professionals